Research analysts at HC Wainwright began coverage on shares of BioHarvest Sciences (NASDAQ:BHST – Get Free Report) in a report issued on Friday,Benzinga reports. The brokerage set a “buy” rating and a $14.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 134.51% from the stock’s current price.
BioHarvest Sciences Trading Down 2.6 %
Shares of NASDAQ:BHST opened at $5.97 on Friday.
Featured Stories
- Five stocks we like better than BioHarvest Sciences
- What is Put Option Volume?
- Ulta Stock Rally: Is There Still Room for More Upside?
- What is a Dividend King?
- Buy the Dip? Chewy Stock’s Growth Story Is Far From Over
- Investing in Travel Stocks Benefits
- Savor Steady Dividends With These 2 High-Yield Value Stocks
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
